drugset / Trial / NCT03393689
RGD PET/MRI in Sporadic Vestibular Schwannoma
NaSingle-groupOpen-labelDiagnostic
Summary
The aim of this non-randomised, prospective study is to investigate the applicability and prognostic value of angiogenesis PET/MR with the radioligand 68Ga-NODAGA- E\[c(RGDyK)\]2 in patients with sporadic Vestibuarl Schwannomas.
Timeline
- Start
- 2018-01-02
- Primary completion
- 2021-01-02
- Completion
- 2021-01-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [68Ga]Ga-NODAGA-E[c(RGDyK)]2 | Diagnostic / imaging agent | 200 mbq | Intravenous |